바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Next
e-Submission

Vol.76 No.5
Citation Share

Diagnostic Tools of Pleural Effusion

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2014, v.76 no.5, pp.199-210

(2014). Diagnostic Tools of Pleural Effusion. Tuberculosis & Respiratory Diseases, 76(5), 199-210.
  • Downloaded
  • Viewed
PDF Download

Abstract

Pleural effusion is not a rare disease in Korea. The diagnosis of pleural effusion is very difficult, even though the patients often complain of typical symptoms indicating of pleural diseases. Pleural effusion is characterized by the pleural cavity filled with transudative or exudative pleural fluids, and it is developed by various etiologies. The presence of pleural effusion can be confirmed by radiological studies including simple chest radiography, ultrasonography, or computed tomography. Identifying the causes of pleural effusions by pleural fluid analysis is essential for proper treatments. This review article provides information on the diagnostic approaches of pleural effusions and further suggested ways to confirm their various etiologies, by using the most recent journals for references.

keywords
Pleural Effusion, Pleurisy, Diagnosis

Reference

1.

1. Light RW. Pleural diseases. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.

2.

2. Light RW. Pleural effusions. Med Clin North Am 2011;95:1055-70.

3.

3. Porcel JM, Light RW. Pleural effusions. Dis Mon 2013;59:29-57.

4.

4. Diaz-Guzman E, Budev MM. Accuracy of the physical examination in evaluating pleural effusion. Cleve Clin J Med 2008;75:297-303.

5.

5. Brims FJ, Davies HE, Lee YC. Respiratory chest pain: diagnosis and treatment. Med Clin North Am 2010;94:217-32.

6.

6. Froudarakis ME. Diagnostic work-up of pleural effusions. Respiration 2008;75:4-13.

7.

7. Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest 2003;124:978-83.

8.

8. Brixey AG, Luo Y, Skouras V, Awdankiewicz A, Light RW. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011;16:1000-4.

9.

9. Qureshi NR, Gleeson FV. Imaging of pleural disease. Clin Chest Med 2006;27:193-213.

10.

10. Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009;64:139-43.

11.

11. Yilmaz U, Polat G, Sahin N, Soy O, Gulay U. CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis 2005;63:17-22.

12.

12. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012;23:727-36.

13.

13. Raptopoulos V, Davis LM, Lee G, Umali C, Lew R, Irwin RS. Factors affecting the development of pneumothorax associated with thoracentesis. AJR Am J Roentgenol 1991;156:917-20.

14.

14. Jones PW, Moyers JP, Rogers JT, Rodriguez RM, Lee YC, Light RW. Ultrasound-guided thoracentesis: is it a safer method? Chest 2003;123:418-23.

15.

15. Menzies SM, Rahman NM, Wrightson JM, Davies HE, Shorten R, Gillespie SH, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011;66:658-62.

16.

16. Hooper C, Lee YC, Maskell N; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65 Suppl 2:ii4-17.

17.

17. Romero-Candeira S, Fernandez C, Martin C, Sanchez-Paya J, Hernandez L. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001;110:681-6.

18.

18. Bielsa S, Porcel JM, Castellote J, Mas E, Esquerda A, Light RW. Solving the Light’s criteria misclassification rate of cardiac and hepatic transudates. Respirology 2012;17:721-6.

19.

19. Porcel JM. Pleural fluid biomarkers: beyond the Light criteria. Clin Chest Med 2013;34:27-37.

20.

20. Villena V, Lopez-Encuentra A, Garcia-Lujan R, Echave-Sustaeta J, Martinez CJ. Clinical implications of appearance of pleural fluid at thoracentesis. Chest 2004;125:156-9.

21.

21. Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003;9:254-60.

22.

22. Putnam B, Elahi A, Bowling MR. Do we measure pleural fluid pH correctly? Curr Opin Pulm Med 2013;19:357-61.

23.

23. Mishra EK, Rahman NM. Factors influencing the measurement of pleural fluid pH. Curr Opin Pulm Med 2009;15:353-7.

24.

24. Heffner JE, Heffner JN, Brown LK. Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions. Chest 2003;123:1887-94.

25.

25. Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010;21:419-23.

26.

26. Sahn SA. Getting the most from pleural fluid analysis. Respirology 2012;17:270-7.

27.

27. Skouras V, Kalomenidis I. Chylothorax: diagnostic approach. Curr Opin Pulm Med 2010;16:387-93.

28.

28. Porcel JM, Bielsa S, Esquerda A, Ruiz-Gonzalez A, Falguera M. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med 2012;23:447-50.

29.

29. Lee SH, Lee EJ, Min KH, Hur GY, Lee SY, Kim JH, et al. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Clin Biochem 2013;46:1484-8.

30.

30. Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-Gonzalez A, Martinez-Iribarren A, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009;34:1383-9.

31.

31. Janda S, Swiston J. Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin: a systematic review and meta-analysis. BMC Pulm Med 2010;10:58.

32.

32. Han CH, Choi JE, Chung JH. Clinical utility of pleural fluid NTpro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern Med 2008;47:1669-74.

33.

33. Porcel JM. Utilization of B-type natriuretic peptide and NTproBNP in the diagnosis of pleural effusions due to heart failure. Curr Opin Pulm Med 2011;17:215-9.

34.

34. Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodriguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004;126:1757-63.

35.

35. Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 1994;7:665-8.

36.

36. Light RW. Update on tuberculous pleural effusion. Respirology 2010;15:451-8.

37.

37. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985;60:158-64.

38.

38. Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003;361:1326-30.

39.

39. Ferrer J, Roldan J, Teixidor J, Pallisa E, Gich I, Morell F. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 2005;127:1017-22.

40.

40. Davies HE, Nicholson JE, Rahman NM, Wilkinson EM, Davies RJ, Lee YC. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 2010;38:472-7.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy